Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots from veins and arteries.
Original Image Link
Source:www.bostonglobe.com
Original Image Link
Source:www.bostonglobe.com
Posted: 2026-01-15 05:29:00















